ロード中...
A Bayesian Adaptive Design for Cancer Phase I Trials Using a Flexible Range of Doses
We present a Bayesian adaptive design for dose finding in cancer phase I clinical trials. The goal is to estimate the maximum tolerated dose (MTD) after possible modification of the dose range during the trial. Parametric models are used to describe the relationship between the dose and the probabil...
保存先:
| 出版年: | J Biopharm Stat |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5832533/ https://ncbi.nlm.nih.gov/pubmed/28858566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2017.1372774 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|